SU5416, Irinotecan, and Cisplatin in Treating Patients With Advanced Solid Tumors

Part of paid clinical trials in Columbus, Ohio.

Sponsor
Ohio State University Comprehensive Cancer Center
Study ID
NCT00006000
Phase
PHASE1
Status
Completed

Conditions

  • Unspecified Adult Solid Tumor, Protocol Specific

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

Study Details

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. SU5416 may stop the growth of solid tumors by stopping blood flow to the tumor. Combining SU5416 with chemotherapy may kill more cancer cells. PURPOSE: Phase I trial to study the effectiveness of SU5416 plus irinotecan and cisplatin in treating patients who have advanced solid tumors.

Key Dates

Start date
Aug 31, 2000
Status verified
Jan 2002
Completion
Mar 31, 2004

Study Design

Primary purpose
TREATMENT

Locations (1)

FacilityCityStateZIPSite coordinators
Arthur G. James Cancer Hospital - Ohio State UniversityColumbusOhio43210-1240-

Find similar trials in Columbus, OH

By research site
Arthur G. James Cancer Hospital - Ohio State University· Columbus, OH

Related Studies